Vascular Health and Risk Management · Nov 12, 2026
Cardiovascular Events After Preeclampsia by Gestational Age at Diagnosis and Severity: A Nationwide Cohort Study
By Chung CH, Ho CH, Chen YC et al.
PURPOSE: Our objective is to evaluate the association between preeclampsia and early major adverse cardiovascular events (MACE), including heart failure, stroke, and myocardial infarction. Additionally, we assessed whether the onset of preeclampsia (EOPE vs LOPE) affects cardiovascular risk differently. By utilizing a large, comprehensive, and nationwide dataset with strong longitudinal follow-up, we aim to evaluate whether gestational age at diagnosis is associated with distinct patterns of cardiovascular health, thereby enhancing postpartum surveillance and preventive strategies in clinical practice. PATIENTS AND METHODS: In this nationwide cohort study using Taiwan's National Health Insurance Research Database (2016-2022), women with preeclampsia were matched 1:10 with controls by age, year, and residential area. The primary outcome was a composite of first hospitalization for myocardial infarction, ischemic stroke, or heart failure. Secondary outcome included all-cause mortality. Cox proportional hazards models were used to estimate adjusted hazard ratios (aHRs). RESULTS: Among 31,694 women with preeclampsia and 316,940 controls, 1.97% and 0.79% developed MACE, respectively. Preeclampsia was associated with increased risks of MACE (aHR 1.81; 95% CI, 1.64-1.99), myocardial infarction (aHR 2.19; 95% CI, 1.34-3.59), stroke (aHR 1.59; 95% CI, 1.41-1.80), heart failure (aHR 3.85; 95% CI, 3.00-4.95), and all-cause mortality (aHR 1.85; 95% CI, 1.50-2.29). Both early- and late-onset preeclampsia were associated with elevated risk, with the largest point estimate observed in those with severe early-onset disease, particularly for heart failure (aHR 10.10; 95% CI, 6.57-15.53). CONCLUSION: Preeclampsia is associated with substantially increased early cardiovascular risk. Both early- and late-onset disease warrant subsequent cardiovascular surveillance, particularly in severe cases.
doi.org/10.2147/vhrm.s639733Open accessPubMed 43042299Populations